Mandate

VINGE ADVISES TOBII IN CONNECTION WITH THE LISTING ON NASDAQ STOCKHOLM

April 28, 2015

Vinge advises Tobii AB (publ) in connection with Tobii’s listing on Nasdaq Stockholm.

Tobii is the global leader in eye tracking, a technology that is used to gain insights in human behavior or as a means to interact with computers and other devices. The Swedish language prospectus was published on 13 April 2015 and the first day of trading was 24 April 2015. The offering price has been set at SEK 25 per share, corresponding to a market value of Tobii of approximately SEK 2.1 billion.

Vinge’s team primarily consisted of Jesper Schönbeck, Johan Winnerblad, Rikard Lindahl, Charlotta Järnstedt and Henrik Wastenson.

Related

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023